Skip to main content
VCbacked
Log inGet Started

BlossomHill Therapeutics

San Diego, United States

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

$84.0M raised
Dec 2025
Series B
BiopharmaBiotechnologyHealth CareOncologyPharmaceutical

Top Investors

Vivo CapitalCormorant Asset ManagementJanus Henderson InvestorsOrbiMedBioTrack Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BlossomHill Therapeutics

How much funding has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $84.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Who are BlossomHill Therapeutics's investors?
BlossomHill Therapeutics's investors include Vivo Capital, Cormorant Asset Management, Janus Henderson Investors, OrbiMed, BioTrack Capital.
Where is BlossomHill Therapeutics headquartered?
BlossomHill Therapeutics is headquartered in San Diego, United States.
What does BlossomHill Therapeutics do?
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
What stage is BlossomHill Therapeutics at?
BlossomHill Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"BlossomHill Therapeutics — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/blossomhill-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). BlossomHill Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/blossomhill-therapeutics
Wikipedia (cite web)
{{cite web |title=BlossomHill Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/blossomhill-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego